CLINICAL_TRIALS
trial_result
· 2022-04-07
Clinical Trial Update: Intranasal Dexmedetomidine Dose-finding Study [Phase 2]
Summary
Phase 2 dose-finding trial of intranasal dexmedetomidine in laceration repair has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Laceration Repair | Phase 2 | Status: COMPLETED